L-Lysine for Canker Sores — Does It Actually Work?

TL;DR

L-lysine is an essential amino acid most commonly recommended for herpes simplex virus (HSV) cold sore suppression, where it has reasonable evidence behind it. For canker sores specifically, the picture is murkier: the proposed mechanism — lysine competing with arginine — was designed for a viral disease. Canker sores are not viral. They are caused by an aberrant immune attack on the oral mucosa. There is limited direct RCT evidence for L-lysine in recurrent aphthous stomatitis (RAS), and what exists shows only modest effects. The supplement is safe and inexpensive, but you should understand what you're actually buying: a reasonable bet with indirect mechanistic logic, not a proven treatment. If you have frequent canker sores and want to try an oral supplement, Vitamin B12 has stronger direct RAS evidence.

The Arginine/Lysine Hypothesis — Where This Started

The rationale for L-lysine comes entirely from HSV cold sore research. Here is the original argument:

• Herpes simplex virus requires the amino acid arginine for viral replication
• Lysine and arginine compete for intestinal absorption via the same transporter (CAT1 — cationic amino acid transporter)
• High dietary lysine suppresses intracellular arginine availability
• Low intracellular arginine inhibits HSV replication
• Therefore: supplementing lysine should suppress HSV outbreaks

This logic is supported by in vitro work (Griffith et al., 1978 — PMID: 310680) and two small placebo-controlled trials in herpes labialis patients (Milman et al., 1980 — PMID: 6116540; McCune et al., 1984 — PMID: 6338592). The results were modest but directionally consistent: lysine supplementation at 1,000–3,000mg/day reduced self-reported cold sore frequency.

The translation to canker sores was a community extrapolation, not a research conclusion. Canker sores were once suspected to involve HSV as a trigger — that hypothesis has since been largely set aside. The current consensus is that RAS is immune-mediated: CD8+ cytotoxic T-cells attack epithelial cells in the oral mucosa, driven by genetic predisposition, stress, and micronutrient status. There is no herpes virus to suppress.

What the Direct RAS Evidence Actually Shows

Direct RCT data for L-lysine in canker sores is limited. Here is what exists:

Canker Sore-Specific Studies

One double-blind crossover study (DiGiovanna & Blank, 1984 — PMID: 6609773) tested L-lysine monohydrochloride at 1,000mg/day in 26 patients with RAS. Result: no statistically significant difference in frequency of aphthous outbreaks between lysine and placebo over a 6-month period.

A retrospective survey (Griffith et al., 1987 — PMID: 3115841) collected self-report data from patients with a mix of conditions including canker sores and found self-reported improvement — but self-reported retrospective surveys without controls do not constitute evidence of efficacy.

The honest summary: the one adequately designed trial found no benefit. The positive signal comes from uncontrolled retrospective reports.

Why the Mechanistic Case Is Weaker for RAS

Even if you accept the arginine/lysine competition model fully:

1. The mechanism is antiviral. RAS is not viral.
2. Arginine has been studied as a potential trigger for RAS outbreaks (some observational reports link high-arginine foods like chocolate and nuts to outbreaks), but this is dietary observational data, not a controlled lysine depletion experiment.
3. The immune dysregulation driving RAS (TNF-α, IL-2, IFN-γ mediated T-cell attack) is not downstream of arginine availability in the way HSV replication is.

The arginine-as-canker-trigger observation is plausible but unconfirmed. Even if arginine restriction helped, it doesn't follow that lysine supplementation would produce the same effect — reducing dietary arginine and raising competing lysine are pharmacologically different interventions.

Who Might Benefit Anyway

Despite weak direct evidence, some RAS patients notice subjective improvement on L-lysine. There are a few reasons this might not be pure placebo:

Nutritional deficiency correction: L-lysine is an essential amino acid — the body cannot synthesize it. Diets low in animal protein (vegan, vegetarian) or with high grain-to-protein ratios can be marginally lysine-deficient. A genuine deficiency, if present, could impair tissue repair and immune function. Supplementation in that context corrects the deficiency rather than providing a pharmacological effect.

Indirect arginine modulation: If a patient genuinely consumes a high-arginine diet (nuts, seeds, chocolate, legumes in large quantities), lysine supplementation may provide some competitive inhibition. This is still extrapolation, but there's at least a partial mechanistic thread.

Overlap with HSV-triggered canker sores: A minority of RAS patients may have lesions partly triggered or amplified by HSV reactivation in the oral mucosa (this remains a minority hypothesis). In that specific subgroup, lysine might provide modest antiviral benefit.

How to Take It (If You Choose To)

If you want to trial L-lysine for canker sore prevention, the approach used in the cold sore trials is the benchmark:

• Dose: 1,000mg/day for maintenance prevention; some protocols use 3,000mg/day during active outbreaks
• Duration: 3–6 months minimum to assess effect — canker sore frequency is variable enough that shorter trials give noisy data
• Form: Any form is fine — capsule, tablet. Absorption differences between forms are clinically insignificant for this application
• Timing: With food reduces potential GI discomfort; otherwise flexible
• Competitive dietary logic: If testing the arginine/lysine theory, reducing dietary arginine sources (chocolate, nuts, seeds, legumes) while supplementing lysine gives the fairest test of the hypothesis

Safety: L-lysine is well-tolerated. No significant drug interactions. High doses (>10g/day) may cause GI upset; doses in the 1,000–3,000mg range are consistently reported as safe in long-term supplementation studies.

Comparison with Better-Evidenced Alternatives

If your goal is reducing canker sore frequency, these supplements have stronger direct RAS evidence:

Vitamin B12 at 1,000mcg/day sublingual is the highest-evidence oral supplement for RAS prevention. See The Best Supplements for Canker Sore Prevention for the full hierarchy.

The Bottom Line on L-Lysine

L-lysine for canker sores is a plausible but unproven extrapolation from cold sore research. The mechanism logic doesn't map cleanly to an immune-mediated disease. The one direct RCT found no significant benefit. The supplement is safe and cheap, so there's minimal downside to a 3-month trial — but don't expect results equivalent to what the cold sore community reports, and don't prioritize it over B12, zinc, or the dietary interventions (SLS-free toothpaste) with proven direct evidence.

If you regularly get cold sores as well as canker sores, L-lysine at 1,000–3,000mg/day is reasonable — it has evidence for the cold sores even if the canker sore benefit remains uncertain.